Proteinase K enhanced immunoreactivity of the prion protein-specific monoclonal antibody 2A11
暂无分享,去创建一个
J. Sánchez-Vizcaíno | J. Castilla | J. Torres | A. Brun | F. Salguero | Alejandro Brun | Joaquı́n Castilla | Miguel A Ramı́rez | Kai Prager | Beatriz Parra | Francisco J Salguero | Diane Shiveral | Carmen Sánchez | José M Sánchez-Vizcaı́no | Alastair Douglas | Juan M Torres | B. Parra | C. Sánchez | M. Ramírez | K. Prager | A. Douglas | Diane Shiveral
[1] S. Prusiner,et al. Scrapie prions aggregate to form amyloid-like birefringent rods , 1983, Cell.
[2] S. Prusiner,et al. Experimental Scrapie in the Mouse: Electrophoretic and Sedimentation Properties of the Partially Purified Agent , 1980, Journal of neurochemistry.
[3] K Wüthrich,et al. NMR solution structure of the human prion protein. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[4] K Wüthrich,et al. NMR characterization of the full‐length recombinant murine prion protein, mPrP(23–231) , 1997, FEBS letters.
[5] P E Wright,et al. Structure of the recombinant full-length hamster prion protein PrP(29-231): the N terminus is highly flexible. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[6] S. Prusiner,et al. Ablation of the prion protein (PrP) gene in mice prevents scrapie and facilitates production of anti-PrP antibodies. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[7] Tomoyuki N. Tanaka,et al. Analyses of Gerstmann–Straussler syndrome with 102Leu219Lys using monoclonal antibodies that specifically detect human prion protein with 219Glu , 2000, Neuroscience Letters.
[8] S. Prusiner,et al. Rapid Acquisition of β-Sheet Structure in the Prion Protein Prior to Multimer Formation , 1998, Biological chemistry.
[9] J. Collinge,et al. Monoclonal antibodies inhibit prion replication and delay the development of prion disease , 2003, Nature.
[10] M. Enari,et al. Scrapie prion protein accumulation by scrapie-infected neuroblastoma cells abrogated by exposure to a prion protein antibody , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[11] S. Itohara,et al. In Vivo Conversion of Cellular Prion Protein to Pathogenic Isoforms, as Monitored by Conformation-specific Antibodies* , 2001, The Journal of Biological Chemistry.
[12] R. Carp,et al. Immune surveillance and antigen conformation determines humoral immune response to the prion protein immunogen. , 1999, Journal of neurovirology.
[13] Pauline M. Rudd,et al. Antibodies inhibit prion propagation and clear cell cultures of prion infectivity , 2001, Nature.
[14] R. Riek,et al. Prion (PrPSc)-specific epitope defined by a monoclonal antibody , 1997, Nature.
[15] C. Korth,et al. Monoclonal antibodies specific for the native, disease-associated isoform of the prion protein. , 1999, Methods in enzymology.
[16] M. Groschup,et al. The use of monoclonal antibody epitopes for tagging PrP in conversion experiments. , 2000, Archives of virology. Supplementum.
[17] K Wüthrich,et al. Three-dimensional structures of prion proteins. , 2001, Advances in protein chemistry.
[18] J. Liddell,et al. A Practical Guide to Monoclonal Antibodies , 1991 .
[19] K Wüthrich,et al. NMR structure of the bovine prion protein. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[20] C. Birkett,et al. A monoclonal antibody that enables specific immunohistological detection of prion protein in bovine spongiform encephalopathy cases , 2001, Neuroscience Letters.
[21] Witold K. Surewicz,et al. Crystal structure of the human prion protein reveals a mechanism for oligomerization , 2002, Nature Structural Biology.
[22] H. Wiśniewski,et al. Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins , 1987, Journal of virology.
[23] E. Harlow,et al. Antibodies: A Laboratory Manual , 1988 .
[24] R. Riek,et al. NMR structure of the mouse prion protein domain PrP(121–231) , 1996, Nature.
[25] P. Lansbury,et al. Species specificity in the cell-free conversion of prion protein to protease-resistant forms: a model for the scrapie species barrier. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[26] J. Miller,et al. Preclinical Diagnosis of Scrapie by Immunohistochemistry of Third Eyelid Lymphoid Tissue , 2000, Journal of Clinical Microbiology.
[27] S. Laboissiere,et al. A prion protein epitope selective for the pathologically misfolded conformation , 2003, Nature Medicine.
[28] Clemencia Pinilla,et al. Mapping the Prion Protein Using Recombinant Antibodies , 1998, Journal of Virology.
[29] M. Moser,et al. Validation of a Western immunoblotting procedure for bovine PrPSc detection and its use as a rapid surveillance method for the diagnosis of bovine spongiform encephalopathy (BSE) , 1999, Acta Neuropathologica.
[30] S. Prusiner,et al. Molecular biology of prion diseases , 1991, Science.
[31] W. Surewicz,et al. Aggregation and fibrillization of the recombinant human prion protein huPrP90-231. , 2000, Biochemistry.
[32] Tong Liu,et al. Differential expression of cellular prion protein in mouse brain as detected with multiple anti-PrP monoclonal antibodies , 2001, Brain Research.
[33] R. Somerville,et al. Immunolocalization of the prion protein in scrapie affected rodent retinas , 1999, Neuroscience Letters.